Shanghai - Delayed Quote CNY
CHINA NATIONAL MEDICINE (600511.SS)
28.99
+0.03
+(0.10%)
At close: April 30 at 3:00:03 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
51,188,309.52
50,597,449.79
49,696,045.53
45,498,583.76
46,468,602.84
Cost of Revenue
47,642,398.62
47,002,226.10
45,704,776.08
41,676,318.10
42,837,500.36
Gross Profit
3,545,910.90
3,595,223.69
3,991,269.45
3,822,265.66
3,631,102.48
Operating Expense
1,406,683.94
1,457,722.46
1,534,114.75
1,420,548.29
1,434,846.69
Operating Income
2,139,226.97
2,137,501.23
2,457,154.69
2,401,717.38
2,196,255.80
Net Non Operating Interest Income Expense
44,350.81
66,090.94
125,574.21
30,491.98
15,630.14
Pretax Income
2,645,953.18
2,653,612.39
2,930,890.24
2,687,885.90
2,444,805.98
Tax Provision
526,229.89
523,831.83
596,419.50
559,180.53
516,303.41
Net Income Common Stockholders
1,999,687.81
2,000,126.94
2,145,998.75
1,964,057.56
1,754,084.22
Basic EPS
2.65
2.65
2.84
2.60
2.32
Diluted EPS
2.65
2.65
2.84
2.60
2.32
Basic Average Shares
754,483.22
754,508.64
754,491
754,507.15
754,509.73
Diluted Average Shares
754,483.22
754,508.64
754,491
754,507.15
754,509.73
Total Operating Income as Reported
2,664,282.83
2,677,421.91
2,944,357.79
2,694,923.45
2,447,274.15
Rent Expense Supplemental
--
10,329.68
24,967.61
27,724.78
27,295.43
Total Expenses
49,049,082.55
48,459,948.56
47,238,890.84
43,096,866.39
44,272,347.05
Net Income from Continuing & Discontinued Operation
1,999,687.81
2,000,126.94
2,145,998.75
1,964,057.56
1,754,084.22
Normalized Income
2,057,641.57
2,057,182.81
2,215,341.80
2,057,620.12
1,872,703.57
Interest Income
84,141.53
106,782.11
166,372
70,801.58
70,735.59
Interest Expense
36,248.27
33,655.84
31,570.18
26,876.92
43,710.09
Net Interest Income
44,350.81
66,090.94
125,574.21
30,491.98
15,630.14
EBIT
2,682,201.45
2,687,268.23
2,962,460.43
2,714,762.82
2,488,516.07
EBITDA
2,682,201.45
2,927,805.93
3,162,210.54
2,904,375.03
2,667,342.92
Reconciled Cost of Revenue
47,642,398.62
47,002,226.10
45,704,776.08
41,676,318.10
42,837,500.36
Reconciled Depreciation
--
240,537.70
199,750.12
189,612.21
178,826.84
Net Income from Continuing Operation Net Minority Interest
1,999,687.81
2,000,126.94
2,145,998.75
1,964,057.56
1,754,084.22
Total Unusual Items Excluding Goodwill
-72,341.01
-71,089.08
-87,059.08
-118,140.11
-150,376.41
Total Unusual Items
-72,341.01
-71,089.08
-87,059.08
-118,140.11
-150,376.41
Normalized EBITDA
2,754,542.46
2,998,895.01
3,249,269.62
3,022,515.14
2,817,719.33
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-14,387.25
-14,033.22
-17,716.03
-24,577.55
-31,757.06
12/31/2021 - 11/27/2002
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade